Cytori to Webcast Cardiac Cell Therapy Teach-In Tuesday Nov. 16 From the American Heart Association

(PresseBox) (San Diego, ) Cytori Therapeutics (NASDAQ: CYTX) will be hosting an investor teach-in on cardiac cell therapy on Tuesday, November 16 from 7:00-8:00 AM CT (8:00-9:00 AM ET) from the American Heart Association meeting in Chicago. The goal is to help investors evaluate the several ongoing clinical trials and approaches to using stem cells for the treatment of heart attacks, heart failure and other vascular diseases. The presentation will be webcast live and can be accessed from the Investor Relations section of Cytori's website at

Investigators from Cytori's APOLLO and PRECISE studies will review their clinical trial experience, the attributes of various sources for stem cells, and how, when and where cells should be delivered. In addition, they will each discuss future directions for the field, including trial design, endpoints, ways to further enhance the effects of the cells, and how such therapies will integrate with current standard-of-care. A Q&A session will be led and moderated by Jan Wald, PhD, of Noble Financial.

Cytori Therapeutics, Inc.

Cytori is a leader in providing patients and physicians around the world with medical technologies that harness the potential of adult regenerative cells from adipose tissue. The Celution® System family of medical devices and instruments is being sold into the European and Asian cosmetic and reconstructive surgery markets but is not yet available in the United States. Our StemSource® product line is sold globally for cell banking and research applications.

Press releases you might also be interested in

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.

I want to subscribe to the gratis press mail and have read and accepted the conditions.